Literature DB >> 12623150

Health-service costs of pediatric cochlear implantation: multi-center analysis.

Garry R Barton1, Karen E Bloor, David H Marshall, A Quentin Summerfield.   

Abstract

OBJECTIVE: Pediatric cochlear implantation (CI) entails surgery followed by lifetime maintenance, and hence incurs both initial and ongoing costs. Previous assessments of these costs were either undertaken early in the evolution of services, or were based on single hospitals, or estimated costs largely from hospital charges. The aim was to overcome these limitations by conducting a multi-center evaluation of the costs of providing unilateral CI to children in the United Kingdom (UK).
METHODS: Annual numbers of implantations in all UK pediatric CI programs were monitored prospectively from 1991. Resource use was measured in 12 programs in 1998/1999 and retrospectively back to the year of inception of each program. The profile of outpatient and outreach visits was assessed in the 12 programs. Together these variables were used to estimate health-service costs for four phases of management: pre-operative assessment, implantation, tuning, and subsequent maintenance, using economic micro-costing methods. Costs were subsequently estimated for all children implanted in 1998/1999 (N=199) and were aggregated over 1, 15, and 73 years following implantation. To assess the robustness of cost estimates, parameter values were varied over plausible ranges and costs re-estimated. Total UK health-service costs were also estimated. All costs are presented in euros (1=US dollars 0.98= pound 0.65, 1st July 2002), inflated to 2000/2001 financial-year levels, and discounted at 6% per annum.
RESULTS: Per-child average costs were 42972 (1-year), 73763 (15-years), and 95034 (73-years). Cost estimates were not overly sensitive to the value of any one cost component nor to the relative cost of outpatient and outreach visits. When these parameters were varied, costs ranged between 30000 and 47000 (1-year), 61000 and 83000 (15-years), and 82000 and 108000 (73-years). The total UK health-service cost of unilateral pediatric CI was estimated to be 14 million in 2000/2001 and is predicted to rise to 23 million in 2015/2016, if the present model of service-delivery continues. The cost of maintaining implanted children was estimated to account for 22% of the total in 2000/2001 and is predicted to rise to 63% by 2015/2016.
CONCLUSIONS: Ongoing costs of maintaining implanted children and their implant systems are significant and should be factored into resource-allocation decisions.

Entities:  

Mesh:

Year:  2003        PMID: 12623150     DOI: 10.1016/s0165-5876(02)00355-5

Source DB:  PubMed          Journal:  Int J Pediatr Otorhinolaryngol        ISSN: 0165-5876            Impact factor:   1.675


  6 in total

1.  Ototoxicity caused by aminoglycosides.

Authors:  Maria Bitner-Glindzicz; Shamima Rahman
Journal:  BMJ       Date:  2007-10-20

2.  The costs of colonoscopy in a Canadian hospital using a microcosting approach.

Authors:  Nour Sharara; Viviane Adam; Ralph Crott; Alan N Barkun
Journal:  Can J Gastroenterol       Date:  2008-06       Impact factor: 3.522

3.  Microcosting quantity data collection methods.

Authors:  Kevin D Frick
Journal:  Med Care       Date:  2009-07       Impact factor: 2.983

4.  Economic Evaluations of Childhood Hearing Loss Screening Programmes: A Systematic Review and Critique.

Authors:  Rajan Sharma; Yuanyuan Gu; Teresa Y C Ching; Vivienne Marnane; Bonny Parkinson
Journal:  Appl Health Econ Health Policy       Date:  2019-06       Impact factor: 2.561

5.  The cost of cochlear implantation: a review of methodological considerations.

Authors:  Costa Nadège; Garnault Valérie; Ferlicoq Laura; Derumeaux-Burel Hélène; Bongard Vanina; Deguine Olivier; Fraysse Bernard; Molinier Laurent
Journal:  Int J Otolaryngol       Date:  2011-10-17

Review 6.  Systematic review of the scientific literature on the economic evaluation of cochlear implants in paediatric patients.

Authors:  G Turchetti; S Bellelli; I Palla; F Forli
Journal:  Acta Otorhinolaryngol Ital       Date:  2011-10       Impact factor: 2.124

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.